News

CBeam by Pulmera transforms existing C-arm infrastructure into scalable intraoperative3D imaging PALO ALTO, Calif., June 2, 2026 — Pulmera, an emerging medical technology company developing next-generation intraoperative imaging solutions, today announced that it has received U.S. Food and Drug Administration 510(k) clearance for its CBeam™ 3D imaging platform. CBeam is designed to transform conventional 2D surgical C-arms into intraoperative 3D imaging systems, helping surgical teams visualize...

We are pleased to announce that Kevin McGann, CEO of Pulmera, has been selected to present at LSI USA ’26, taking place March 16–20, 2026 at the Waldorf Astoria in Monarch Beach, California. Kevin will present on March 19th at 3:00 PM, where he will introduce Pulmera and share insights into our proprietary C-Beam™ technology, along with our strategic pathway toward commercialization in 2026. The LSI conference brings together leading innovators, investors, and executives in the...